Back

drs. C. (Chris) van Lieshout

drs. C. (Chris) van Lieshout

Assistant Professor
drs. C. (Chris) van Lieshout
  • Julius Center, dept. Epidemiology & Health Economics

Biography

Biography

I am a researcher of health economics at the department of Epidemiology and Health Economics at the Julius Center, UMCU. In general and since the start of my scientific career, my research focusses on early health economic evaluations. Currently my research focusses on the methodology of early health economic analyses alongside early phase adaptive trials within Oncode Accelerator. Next to my work at Oncode Accelerator, I am involved in several health economic evaluation projects in oncology.  Between 

Previously I completed my master of sciences in Health Sciences at the University of Twente. I conducted the research for my thesis at the Netherlands Cancer Institute Antoni van Leeuwenhoek (NKI-AVL) in Amsterdam focussing on the health technology assessment of HIPEC added to cytoreductive surgery in patients with state III ovarian cancer. Before starting my masters I completed my bachelor of science in Health Sciences at the University of Twente as well. My bachelorthesis was about the diagnositc properties of enzym based diagnostics in diabetic foot ulcers. 

Research Output (10)

Krankenhauskosten und gesundheitsbezogene Lebensqualität bei Patienten mit Delir:ein Scoping-Review

van Lieshout Chris, Schuit Ewoud, Hermes Carsten, Kerrigan Matthew, Frederix Geert W J 11 Mar 2022, In: Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen. 169 , p. 28-38 11 p.

Cost-Effectiveness of a Multidisciplinary Lifestyle-Enhancing Treatment for Inpatients with Severe Mental Illness:The MULTI Study v

Deenik Jeroen, Van Lieshout Chris, Van Driel Harold F., Frederix Geert W.J., Hendriksen Ingrid J.M., Van Harten Peter N., Tenback Diederik E. 1 Jan 2022, In: Schizophrenia Bulletin Open. 3

Cerebrospinal fluid leakage costs after craniotomy and health economic assessment of incidence reduction from a hospital perspective in the Netherlands

van Lieshout Chris, Slot Emma M H, Kinaci Ahmet, Kollen Mare H, Hoving Eelco W, Frederix Geert W J, van Doormaal Tristan P C 16 Dec 2021, In: BMJ Open. 11

Accuracy of approximations to recover incompletely reported logistic regression models depended on other available information

Takada Toshihiko, Hoogland Jeroen, van Lieshout Chris, Schuit Ewoud, Collins Gary S, Moons Karel G M, Reitsma Johannes B 1 Dec 2021, In: Journal of Clinical Epidemiology. 143 , p. 81-90 10 p.

Advanced image-supported lead placement in cardiac resynchronisation therapy:protocol for the multicentre, randomised controlled ADVISE trial and early economic evaluation

Wouters Philippe C, van Lieshout Chris, van Dijk Vincent F, Delnoy Peter-Paul Hm, Doevendans Pieter Afm, Cramer Maarten J, Frederix Geert Wj, van Slochteren Frebus J, Meine Mathias 25 Oct 2021, In: BMJ Open. 11 , p. 1-8

SAFE@HOME:Cost analysis of a new care pathway including a digital health platform for women at increased risk of preeclampsia

van den Heuvel Josephus F.M., van Lieshout Christiaan, Franx Arie, Frederix Geert, Bekker Mireille N. Jun 2021, In: Pregnancy Hypertension. 24 , p. 118-123 6 p.

Continuation of Anti-TNF in Patients With Ulcerative Colitis in Remission Is Not Cost-effective Compared With Treatment Withdrawal:a Markov Model

Mahmoud Remi, van Lieshout Chris, Frederix Geert W J, Jharap Bindia, Oldenburg Bas 30 Oct 2020, In: Journal of Crohn's & Colitis. 15 , p. 709-718 10 p.

MRI-guided pulmonary vein isolation for atrial fibrillation:What is good enough? An early health technology assessment

Wenker Steven, Van Lieshout Chris, Frederix Geert, Van Der Heijden Jeroen, Loh Peter, Chamuleau Steven A.J., Van Slochteren Frebus 11 Nov 2019, In: Open Heart. 6

Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial

Koole Simone N., Van Lieshout Christiaan, Van Driel Willemien J., Van Schagen Evi, Sikorska Karolina, Kieffer Jacobien M., Schagen van Leeuwen Jules H., Schreuder Henk W.R., Hermans Ralph H., De Hingh Ignace H., Van der Velden Jacobus, Arts Henriette J., Massuger Leon F.A.G., Aalbers Arend G., Verwaal Victor J., Van de Vijver Koen K., Aaronson Neil K., Tinteren Harmvan, Sonke Gabe S., Van Harten Wim H., Rete'l Valesca P. Oct 2019, In: Obstetrical and Gynecological Survey. 74 , p. 592-593 2 p.

Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial

Koole Simone N., van Lieshout Christiaan, van Driel Willemien J., van Schagen Evi, Sikorska Karolina, Kieffer Jacobien M., van Leeuwen Jules H. Schagen, Schreuder Henk W. R., Hermans Ralph H., de Hingh Ignace H., van der Velden Jacobus, Arts Henriette J., Massuger Leon F. A. G., Aalbers Arend G., Verwaal Victor J., Van de Vijver Koen K., Aaronson Neil K., van Tinteren Harm, Sonke Gabe S., van Harten Wim H., Retel Valesca P. 28 Jun 2019, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37 , p. 2041-2050 10 p.

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not